🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are encouraged to message these profiles privately for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Additionally, a flourishing market exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and claims of next-day British shipping. Vendors market the substance there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Experts Express Concerns

However, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is worrisome and could lead to users injecting substances of unknown origin.

Several experts said the demand for the experimental drug could be linked to the rising price of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the British medical regulations.

Several influencers try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, advertising, and consumer regulations, risking fines, prosecution or prison.

Service Reaction and Material Removal

Based on TikTok, the service has taken down problematic material and banned related hashtags and query recommendations. The organization stated it was committed to keeping the service safe and investing in enhancing compliance measures.

Online Marketplace Activities

Research also found groups with up to nine thousand members marketing the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with numerous of users, filled with images of weight loss, glowing testimonials and step-by-step instructions for mixing or injecting at residence.

After minutes of joining one group, a vendor shared WhatsApp details, where the majority of transactions occur. The vendor sent an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about weight, health issues or previous experience.

Product Details and Costs

Inside these communities, messages show black plastic packages with postal service stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When asked how long a injector should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service said it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering substances they cannot confirm. Although the science behind this drug is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has already seen individuals harmed by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company experimental substance not yet authorized … may expose users to possibly serious medical dangers”.